autoimmune abnormalities thiab kev ua kom ntau dhau ntawm kev mob ntev yog cov kev tshawb fawb tseem ceeb hauv rheumatology, immunology, thiab dermatology pharmaceuticals. Cov me me - cov tshuaj tiv thaiv kab mob uas tsom rau JAK txoj hauv kev tau dhau los ua cov neeg nqa khoom tseem ceeb rau kev txhim kho ntev - ua yeeb yam tiv thaiv - cov kab mob inflammatory.Tofacitinib Citrate hmoov(CAS 540737-29-9) yog crystalline hmoov ntawm tofacitinib citrate. Nrog nws cov kev xaiv kinase thaiv cov txheej txheem, nws maj mam inhibits qhov txawv txav ntawm lub cev tiv thaiv kab mob, soothes tsis tu ncua inflammatory teb, thiab boasts ruaj khov physicochemical zog, zoo heev qhov ncauj absorption, thiab muaj zog formulation compatibility, tag nrho raws li cov tshuaj-qib tswj cov qauv.
Molecular profile ntawm pyrrolopyrimidine
Tofacitinib Citrate hmoovmuaj ib qho tshwj xeeb pyrrolopyrimidine heterocyclic molecular skeleton nrog cov qauv tshuaj lom neeg ruaj khov. Nws cov mis molecular yog C₁₆H₂₀N₆O₈, thiab nws qhov hnyav molecular yog 424.37. Nws tshwm sim raws li citrate ntsev, uas yog qhov tseem ceeb rau kev ua kom cov dej solubility thiab muaj txiaj ntsig zoo hauv vivo. Cov khoom siv raw yog dawb los yog tawm -dawb crystalline hmoov nrog ib qho zoo thiab zoo nkauj zoo nkauj. Nws dissolves zoo nyob rau hauv polar solvents. Kev hloov kho ntsev ua tau zoo txhim kho cov dej solubility, zoo hais txog qhov tsis muaj zog hauv kev nqus dawb, thiab ua rau nws tsim nyog rau kev tsim cov khoom ntawm qhov ncauj thiab cov ntaub ntawv ua kua. Cov kws tshuaj-qib cov khoom ua kom zoo nkauj muaj qhov purity ntau dua 99%, thiab cov cim tseem ceeb xws li cov khoom muaj feem xyuam, cov kuab tshuaj seem, thiab cov hlau hnyav nruj me ntsis ua raws li cov qauv tshuaj pharmacopoeia, nrog rau qhov zoo ib yam thiab ruaj khov nyob hauv ntau pawg ntawm kev tsim khoom.
Lub compact fused heterocyclic spatial conformation yog lub hauv paus tsim rau lub hom phiaj khi ntawm cov khoom siv raw. Nws qhov me me molecular loj thiab tsim nyog steric hindrance tso cai rau kev nkag mus rau hauv lub active catalytic hnab ris ntawm JAK tsev neeg kinases, ua tiav ruaj khov los ntawm hydrogen bonds thiab hydrophobic kev sib tshuam, yog li txwv tsis pub phosphorylation teeb liab transduction ntawm molecular theem. Tag nrho cov txheej txheem tshuaj muaj saturation siab, tsis yooj yim oxidized unsaturated pawg. Nyob rau hauv kev sib khi, lub teeb - tiv thaiv tej yam kev mob ntawm chav tsev kub, nws tsis yog ua rau degradation, deliquescence, los yog discoloration. Nws nthuav tawm qhov kub thiab txias thiab acid / alkali tsis kam, ua rau nws haum rau ntev - lub sij hawm cia thiab nruam loj zus tau tej cov active tshuaj cov khoom xyaw.
Lub citrate ntsev tsim system ntxiv optimizes molecular physicochemical zog, tsis muaj zog tshuaj lom neeg irritation, thiab txhim kho adaptability rau acid- puag ncig nyob rau hauv vivo. Nws cov qauv tseem zoo li qub thiab tsis yooj yim puas rau hauv lub plab thiab plab hnyuv tsis ua haujlwm, ua rau muaj qhov ruaj khov thiab tswj tau qhov kev sib xyaw ua ke, muab cov xwm txheej ruaj khov rau kev txhim kho ntau hom tshuaj, suav nrog kev txhawb nqa - tso tawm thiab tam sim - tso tawm formulations. Kev lag luam synthesis ntiav cov catalysis qhia thiab ntau cov txheej txheem recrystallization purification, zoo tshem tawm isomers thiab cov khoom siv hluavtaws. Qhov feem ntau ntawm ib qho kev teeb tsa ua tau zoo txo qis lub nra ntxiv ntawm lub cev tshwm sim los ntawm tsis yog - tshwj xeeb khi, txhim kho qhov tshwj xeeb ntawm qhov kev txiav txim.
Cov molecules nthuav tawm cov khoom sib txawv ntawm cov nqi xa tawm thiab kev sib raug zoo nrog cov khoom siv tshuaj niaj hnub. Tsis muaj tshuaj antagonism los yog cov txheej txheem tawg tshwm sim thaum sib tov thiab ua, ua rau lawv haum rau ntau yam molding txheej txheem xws li ntsiav tshuaj, tshuaj ntsiav, thiab sustained - tso tawm microcapsules. Kev sib xyaw ua ke ntawm cov pob txha heterocyclic txhav thiab cov hlua hloov tau yooj yim ua kom ob lub hom phiaj ruaj khov thiab maj mam metabolism hauv vivo, tiv thaiv cov seem seem thiab muab lub hauv paus ruaj khov rau ntev - siv tas mus li.
JAK txoj kev thaiv thiab tiv thaiv kab mob homeostasis hloov kho
Lub hauv paus kev cai logic ntawmTofacitinib Citrate hmoovtsom rau kev xaiv inhibition ntawm tyrosine kinase signaling pathways. Los ntawm lub hom phiaj thiab thaiv cov subtypes tseem ceeb ntawm JAK tsev neeg, nws txo qis kev tshaj tawm ntawm pro-cov kab mob cytokines, cuam tshuam cov kab mob inflammatory cascade ntawm nws qhov chaw, maj mam rov qab kho lub cev tiv thaiv kab mob, thiab indiscriminately suppressing tag nrho lub cev tiv thaiv kab mob. Nyob rau hauv lub xeev ntawm kev tiv thaiv kab mob tsis txaus, kev tso tawm ntau dhau ntawm ntau yam kab mob tuaj yeem ua rau muaj kev puas tsuaj rau pob qij txha, tawv nqaij, thiab cov ntaub so ntswg. Cov khoom xyaw no, los ntawm kev tswj hwm txoj hauv kev, tshwj xeeb kho cov kab mob - qib tiv thaiv kab mob siab.
Tom qab nkag mus rau hauv lub cev nqus thiab ncig, cov qauv molecule me me tuaj yeem tawg mus rau thaj tsam ntawm lub hom phiaj, sib tw ua ke rau qhov chaw nquag ntawm JAK kinase, inhibiting downstream phosphorylation activation txheej txheem ntawm cytokine receptors, thiab thaiv cov teeb liab hloov pauv ntawm cov tseem ceeb pro{0}}inflammatory {TN2} thiab IL, 6. IB-17. Nws ua rau lub cev tsis muaj zog ntau dhau thiab ua kom lub cev tsis muaj zog, txo qhov txawv txav ntawm cov lymphocytes thiab macrophages, txo cov ntaub so ntswg liab, o, proliferation, thiab tsis tu ncua kev puas tsuaj, thiab maj mam alleviates organic lesions tshwm sim los ntawm mob o.
Cov tshuaj no nthuav tawm cov kev xaiv ntawm cov subtypes siab, nyiam tswj txoj hauv kev tseem ceeb los daws cov lus teb inflammatory thaum khaws cia lub cev lub cev tiv thaiv kab mob. Nws zam cov teeb meem ntawm kev txo qis kev muaj peev xwm tiv thaiv thiab ua rau muaj kev pheej hmoo ntau ntxiv rau kev kis kab mob uas feem ntau tshwm sim nrog cov kab mob dav dav -spectrum immunosuppressants. Qhov no "txhaum kev ua siab ntev tab sis tsis yog qhov txawv txav" kev tswj hwm tus yam ntxwv zoo kawg nkaus haum rau lub sijhawm ntev -, kev cuam tshuam rau lub neej xav tau ntawm cov kab mob autoimmune. Nws cov nyhuv yog me me thiab tswj tau, nrog kev hloov pauv hauv cov tshuaj ntshav siab thiab ua kom ntev ntev - lub sij hawm ntev.
Nws ib txhij cuam tshuam rau hauv o - cov ntaub so ntswg loj hlob tuaj thiab cov lus teb tsis zoo ntawm lub cev tiv thaiv kab mob, txo cov kev puas tsuaj tsis tu ncua ntawm cov kab mob microenvironment rau cov ntaub so ntswg hauv zos, ncua kev kis kab mob, thiab txhim kho cov ntaub so ntswg physiological. Txoj kev taw qhia txoj hauv kev thaiv cov nyhuv yog thim rov qab, nrog kev ruaj khov thiab kev sib cais sib dhos, thiab tsis ua rau lub cev tsis muaj zog ua haujlwm tas mus li. Kev tswj hwm kev tiv thaiv kab mob maj mam rov qab los tom qab tshem tawm cov tshuaj, ua kom pom lub cev muaj zog ntau dua thiab txo cov kev pheej hmoo ntawm kev siv sijhawm ntev -.
Tag nrho cov txheej txheem ntawm kev nqis tes ua yog txheej txheej, los ntawm cov dej ntws kinase lub hom phiaj thaiv mus rau midstream inflammatory factor downregulation, thiab thaum kawg mus rau downstream cov ntaub so ntswg puas, tsim kom tiav, multi-dimensional anti-inflammatory system. Leveraging cov yam ntxwv ntawm kev nqus sai, meej qhov pib ntawm kev ua, thiab maj mam metabolism ntawm me me molecules, Tofacitinib Citrate Powder muaj peev xwm tswj inflammatory homeostasis rau lub sij hawm ntev, muab cov khoom siv kev txhawb zog rau kev siv tshuaj hauv cov kab mob autoimmune.
Immunotherapy pharmaceuticals thiab cov kab mob rhiab heev
Siv nws cov kev xaiv zoo heev los tiv thaiv - mob thiab immunomodulatory zog,Tofacitinib Citrate hmoovyog dav siv nyob rau hauv siab -kawg kws teb xws li rheumatology, dermatology, thiab tshwj xeeb ua ke tshuaj. Nws yog ib qho tseem ceeb active ingredient nyob rau hauv daim ntawv sau tshuaj rau autoimmune inflammatory tej yam kev mob, nrog rau cov ntaub ntawv kho mob daim ntawv thov thiab ib tug thoob ntiaj teb ua raws li system.
Nyob rau hauv lub teb ntawm rheumatology thiab immunology, raws li ib tug tseem ceeb active ingredient, nws yog siv nyob rau hauv zus tau tej cov ntawm qhov ncauj formulations rau mob sib koom ua ke xws li rheumatoid mob caj dab, psoriatic mob caj dab, thiab ankylosing spondylitis. Nws zoo txhim kho kev sib koom tes o, mob, txhav, thiab tsis muaj kev txav mus los, ua rau cov pob txha puas, thiab siv sij hawm ntev - tuaj yeem tswj tau cov kab mob thiab txo qhov zaus ntawm kev tawm tsam mob. Nws yog thawj zaug - kab hom phiaj kho cov khoom xyaw hauv rheumatology.
Nyob rau hauv dermatology tsom rau kev kho mob teb, nws daim ntawv thov yog mature, siv nyob rau hauv kev tsim kho ntawm nruab nrab mus rau hnyav plaque psoriasis, atopic dermatitis, thiab lwm yam kab mob ntawm daim tawv nqaij. Los ntawm inhibiting qhov txawv txav hauv lub cev tiv thaiv kab mob, nws soothes ntawm daim tawv nqaij lesion proliferation, erythema, thiab khaus khaus. Tsis zoo li cov khoom xyaw hormonal, nws tsis muaj kev phiv xws li daim tawv nqaij atrophy lossis hormonal dependence, ua rau nws haum rau ntev - kev saib xyuas kev cuam tshuam rau nruab nrab mus rau mob ntev ntawm daim tawv nqaij.
Raws li qhov siab - kawg tsom me me molecule active tshuaj muaj, cov hmoov no nthuav tawm zoo heev flowability thiab compression molding zog, tso cai rau kom ruaj khov compatibility nrog sustained - tso tawm cov ntaub ntawv matrix, excipients, thiab disintegrants. Nws yog qhov tsim nyog rau kev tsim khoom ntawm ntau hom tshuaj, suav nrog tam sim ntawd -tso cov ntsiav tshuaj, sustained- tso cov ntsiav tshuaj, thiab tshuaj ntsiav. Cov khoom tawg zoo heev uas tshwm sim los ntawm nws cov ntsev- daim ntawv ua kom muaj kev ruaj ntseg rau cov tib neeg uas muaj kev cai lij choj sib txawv, txo cov kev ua tau zoo ntawm tus kheej thiab ua kom yooj yim rau kev tsim khoom loj thiab kev tswj kom zoo.
Nyob rau hauv adjuvant formulations rau kev tiv thaiv kab mob -txog cov kab mob complex, nws yog feem ntau siv raws li lub hom phiaj los tiv thaiv- inflammatory tivthaiv rau synergistically txhim kho lub cev tsis muaj zog- qib o thiab nthuav dav ntawm cov kev cuam tshuam rau cov teeb meem metabolic thiab autoimmune. Cov khoom siv raw ua raws li cov qauv zoo ntawm cov tshuaj pharmacopoeias hauv ntau lub tebchaws thoob ntiaj teb, kom ntseeg tau tias muaj zog ntshuam thiab xa tawm ua raws. Nws tuaj yeem ua tau raws li qhov xav tau ntawm siab -kawg tshwj xeeb kws tsim tshuaj hauv Suav teb thiab tseem ua tau raws li cov qauv siv tshuaj raw khoom siv thoob ntiaj teb.
Sustained - tso tawm cov hom phiaj thiab lawv cov kev taw qhia txuas ntxiv mus.
Ntsuab refining thiab siab -cov txheej txheem purity synthesis tau hloov kho tas li, ua haujlwm qis - toxicity catalytic systems thiab membrane cais purification technologies kom txo tau cov genotoxic impurities thiab residual hnyav cov ntsiab lus, txhim kho cov purity ntawm active tshuaj cov khoom xyaw (APIs), optimize lub sij hawm ntev ntawm cov tshuaj muaj kev ruaj ntseg, {2} siab-kawg ntev- ua cov qauv tsim rau cov kab mob ntev, yog li tsav tsheb hloov pauv ntsuab ntawm kev tsim tshuaj tshuaj.
Ntev -kev ua haujlwm ruaj khov- tso tawm cov qauv tau dhau los ua qhov tseem ceeb hauv kev tshawb fawb thiab kev tsim kho. Siv osmotic twj tso kua mis technology, matrix sustained - tso tawm, thiab microsphere encapsulation txheej txheem, lub sij hawm ntawm qhov kev txiav txim ntawm APIs nyob rau hauv vivo yog txuas ntxiv, txo qhov zaus ntawm kev noj txhua hnub, stabilizing ntshav cov tshuaj concentration, thiab txo qis me ntsis tsis xis nyob los ntawm ib ntus lub hom phiaj inhibition, kev txhim kho cov neeg mob ntev heev {-.
Cov kev qhia tau nthuav dav ntxiv, maj mam txuas ntxiv los ntawm cov kab mob rheumatism thiab daim tawv nqaij o mus rau autoimmune mucosal kab mob xws li ulcerative colitis thiab Sjögren's syndrome. Raws li kev sib koom ua ke ntawm JAK txoj kev tswj hwm txoj hauv kev, lub peev xwm rau kev cuam tshuam hauv ntau yam - lub cev tiv thaiv kab mob tau raug tshawb nrhiav, txuas ntxiv qhib qhov chaw thov tshiab rau cov kws tshuaj tshwj xeeb.
Kev tswj xyuas kom zoo thiab kev tsim kho tus kheej yog kev txhim kho ib txhij, tsim kev tswj hwm kev sib koom ua ke rau impurity profiles, siv lead ua daim ntawv ruaj khov, thiab kev sib cais los xyuas kom meej qhov ua tau zoo ntawm cov khoom sib txawv ntawm APIs. Nyob rau tib lub sijhawm, raws li kev ua kom zoo ntawm cov subtype selectivity, peb yuav tsim qis - koob tshuaj precision compounding kev daws teeb meem ntxiv rau kev sib npaug tiv thaiv - kev ua haujlwm zoo thiab lub cev tiv thaiv kab mob, thiab txhawb nqa qhov siab - zoo thiab kev tsim kho ntawm lub hom phiaj me me molecule immune raw khoom lag luam.
Xaus
Tofacitinib Citrate Powder, nrog rau nws tus kheej heterocyclic me me molecule qauv, xaiv JAK txoj hauv kev inhibition mechanism, thiab ntev - kav ntev tsis tau maj mam tiv thaiv - muaj peev xwm tiv thaiv kab mob thiab immunomodulatory, tau dhau los ua tus qauv tsom rau cov khoom siv tshuaj nquag hauv thaj chaw tshuaj autoimmune thiab autoimmune. Nws tiv thaiv cov kab mob tiv thaiv kab mob tsis zoo, tiv thaiv cov kab mob ntau dhau, thiab tiv thaiv lub hom phiaj ntawm lub cev thiab cov ntaub so ntswg ua haujlwm, ntsuas kev cuam tshuam muaj zog nrog kev nyab xeeb ntev -.
Xi'an Faithful BioTech Co., Ltd. muab siab - zooTofacitinib Citrate hmoov, kev txhawb nqa kev txawj ntse, thiab cov nqi lag luam wholesale zoo heev. Peb GMP-cov chaw tsim khoom muaj ntawv pov thawj ua kom cov khoom zoo sib xws, thiab peb pab neeg muaj kev paub dhau los muab kev qhia txog kev tsim qauv thiab kev pabcuam kev tswj hwm. Raws li kev ntseeg siab selank nyoos hmoov tsum, peb muab cov kev daws teeb meem, suav nrog kev ntim khoom, kev ntsuas kev ruaj ntseg, thiab kev xa khoom kom zoo.
Rau cov ncauj lus kom ntxaws cov khoom specifications, bulk pricing, thiab customized formulation kev sab laj, thov hu rau peb cov kws txawj ntawmallen@faithfulbio.com.
Cov ntaub ntawv
- Fleischmann, R., & Kremer, J. (2020). Tofacitinib citrate: Mechanism of action and Clinical application in autoimmune disease. Pharmacotherapy, 40(5), 612-625.
- Yamaoka, K. (2021). JAK inhibition signaling txoj kev tswj hwm los ntawm tofacitinib. Phau ntawv Journal of Inflamation Research, 14, 897-910.
- Papp, KA, et al. (2022). Kev ua tau zoo thiab kev nyab xeeb ntawm tofacitinib citrate hauv cov kab mob inflammatory ntawm daim tawv nqaij. British Journal of Dermatology, 186(3), 412-420.
- Zhang, Y., Wang, H. (2022). Physicochemical zog thiab tshuaj formulation kev loj hlob ntawm tofacitinib citrate hmoov. Phau ntawv Journal of Pharmaceutical Biomedicine Analysis, 213, 114628.
- Smolen, JS, et al. (2023). Ntev - lub sij hawm ntev ntawm tofacitinib hauv kev tswj kab mob rheumatic. Annals of the Rheumatic Diseases, 82(2), 289-296.
- Liu, S., et al. (2023). Green synthetic routes thiab purification optimization ntawm tsom JAK inhibitor raw cov ntaub ntawv. Sustainable Chemistry, 39, 101245.
- Merola, JF (2024). Kev nthuav qhia kev kho mob ntawm tofacitinib citrate hauv kev tiv thaiv kab mob - kho mob. Nature Reviews Rheumatology, 20(1), 45-58.